Novel Therapies: How CAR T Cells and Biosimilars Are Changing Cancer Care
Chris Pirschel ONS Staff Writer
Voice
Description
Clinical practice is in a constant state of evolution as new guidelines are released, drugs are approved for new indications, and technology reshapes the way care is delivered.